Related content

Targeting a Genetic Killer: Novel Disease-Modifying Therapies for Cystic Fibrosis

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 4, 2006-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target

By  

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1535-1544

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory Effects of Macrolide Antibiotics in Respiratory Disease: Therapeutic Implications for Asthma and Cystic Fibrosis

By Sharma Sanjiv  

Pediatric Drugs, Vol. 9, Iss. 2, 2007-01 ,pp. : 107-118

Adis International

Access to resources Recommend Favorite

Cystic Fibrosis and the Innate Immune System: Therapeutic Implications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 1, 2011-03 ,pp. : 8-22

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for cystic fibrosis lung disease

By Grasemann Hartmut   Ratjen Felix  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 653-659

Informa Healthcare

Access to resources Recommend Favorite